HMGB1 and colorectal cancer: When HMGB1 is passively released from dying tumour cells following chemotherapy in colorectal cancer, HMGB1 facilitates autophagy following cytotoxic insults for chemoresistance via its RAGE receptor via the MEK/ERK signaling pathway.